Trial intelligence / Profile preview

Perioperative magnesium sulfate as a cerebral protector in neurosurgical patients

2011-006301-10Phase 3Active

Sponsor
Fundació Clínic per a la Recerca Biomèdica
Start
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of magnesium sulfate in epilepsy and brain neoplasm, sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Serum S100B protein levels perioperatively. Started Apr 2012; status: active.

02

Drugs

magnesium sulfate
03

Conditions

epilepsybrain neoplasm

Beyond the preview

Go deeper on 2011-006301-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-006301-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call